FIELD: pharmacology.
SUBSTANCE: invention is a pharmaceutical composition for the suppression of blood cancers comprising, as an active ingredient, monoacetyl diacylglycerol represented by the formula 1 wherein R1 and R2 independently represent a fatty acid group of 14-20 carbon atoms and a pharmaceutically acceptable carrier, excipient or diluent, cancerous blood disease is selected from the group consisting of lymphomas, acute leukemias, chronic leukemias and multiple myeloma.
EFFECT: expansion of the arsenal of funds for the treatment of lymphomas, acute leukemias, chronic leukemia and multiple myeloma.
11 cl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING MONOACETYLDIACYLGLYCERIDE AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS | 2014 |
|
RU2646823C2 |
| METHODS OF TREATING LEUKOPENIA AND THROMBOCYTOPENIA | 2015 |
|
RU2702122C2 |
| COMPOSITION FOR ATOPIC ECZEMA PREVENTION OR TREATMENT CONTAINING MONOACETYLDIACYL GLYCERINE COMPOUND AS ACTIVE INGREDIENT | 2014 |
|
RU2640503C2 |
| COMPOSITION FOR ASTHMA PREVENTION OR TREATMENT CONTAINING MONOACETHYLDIACYL GLYCERINE COMPOUND AS ACTIVE INGREDIENT | 2014 |
|
RU2636615C2 |
| COMPOSITION FOR PREVENTION OR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASES CONTAINING MONOACETHYLDIGLYCEROL COMPOUNDS AS ACTIVE INGREDIENT | 2014 |
|
RU2642631C2 |
| IMMUNOMODULATORY AGENT, CANCER AGENT AND HEALTHY FOOD CONTAINING MONOACETYLDIACYLGLYCERIN DERIVATIVES | 2005 |
|
RU2341257C2 |
| NEW LIPOSOME COMPOSITIONS | 2006 |
|
RU2454229C2 |
| ANTIBODY-DRUG CONJUGATE HAVING IMPROVED STABILITY AND USE THEREOF | 2014 |
|
RU2670748C9 |
| NOVEL DUAL-TARGETED PROTEINS SPECIFICALLY BINDING TO DLL4 AND VEGF, AND USE THEREOF | 2014 |
|
RU2648154C2 |
| COMPOSITION FOR TREATMENT OF CANCER ASSOCIATED WITH HPV INFECTION | 2013 |
|
RU2636003C2 |
